de Jong MAWP - Search Results

1

Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021.

Deeks SG, Archin N, Cannon P, Collins S, Jones RB, de Jong MAWP, Lambotte O, Lamplough R, Ndung'u T, Sugarman J, Tiemessen CT, Vandekerckhove L, Lewin SR; International AIDS Society (IAS) Global Scientific Strategy working group. Deeks SG, et al. Among authors: de jong mawp. Nat Med. 2021 Dec;27(12):2085-2098. doi: 10.1038/s41591-021-01590-5. Epub 2021 Dec 1. Nat Med. 2021. PMID: 34848888 Review.

2

Langerin is a natural barrier to HIV-1 transmission by Langerhans cells.

de Witte L, Nabatov A, Pion M, Fluitsma D, de Jong MA, de Gruijl T, Piguet V, van Kooyk Y, Geijtenbeek TB. de Witte L, et al. Nat Med. 2007 Mar;13(3):367-71. doi: 10.1038/nm1541. Epub 2007 Mar 4. Nat Med. 2007. PMID: 17334373

3

Herpes simplex virus type 2 enhances HIV-1 susceptibility by affecting Langerhans cell function.

de Jong MA, de Witte L, Taylor ME, Geijtenbeek TB. de Jong MA, et al. J Immunol. 2010 Aug 1;185(3):1633-41. doi: 10.4049/jimmunol.0904137. Epub 2010 Jun 30. J Immunol. 2010. PMID: 20592277 Free article.

4

Langerhans cells in innate defense against pathogens.

de Jong MA, Geijtenbeek TB. de Jong MA, et al. Trends Immunol. 2010 Dec;31(12):452-9. doi: 10.1016/j.it.2010.08.002. Epub 2010 Oct 26. Trends Immunol. 2010. PMID: 21030306 Review.

5

TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo.

de Jong MA, de Witte L, Oudhoff MJ, Gringhuis SI, Gallay P, Geijtenbeek TB. de Jong MA, et al. J Clin Invest. 2008 Oct;118(10):3440-52. doi: 10.1172/JCI34721. J Clin Invest. 2008. PMID: 18776939 Free PMC article.

6

Langerhans Cell-Dendritic Cell Cross-Talk via Langerin and Hyaluronic Acid Mediates Antigen Transfer and Cross-Presentation of HIV-1.

van den Berg LM, Cardinaud S, van der Aar AM, Sprokholt JK, de Jong MA, Zijlstra-Willems EM, Moris A, Geijtenbeek TB. van den Berg LM, et al. J Immunol. 2015 Aug 15;195(4):1763-73. doi: 10.4049/jimmunol.1402356. Epub 2015 Jul 13. J Immunol. 2015. PMID: 26170391

7

Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4⁺ T cells but are incapable of cross-presentation.

van der Vlist M, de Witte L, de Vries RD, Litjens M, de Jong MA, Fluitsma D, de Swart RL, Geijtenbeek TB. van der Vlist M, et al. Eur J Immunol. 2011 Sep;41(9):2619-31. doi: 10.1002/eji.201041305. Epub 2011 Aug 8. Eur J Immunol. 2011. PMID: 21739428 Free article.

8

Mutz-3-derived Langerhans cells are a model to study HIV-1 transmission and potential inhibitors.

de Jong MA, de Witte L, Santegoets SJ, Fluitsma D, Taylor ME, de Gruijl TD, Geijtenbeek TB. de Jong MA, et al. J Leukoc Biol. 2010 Apr;87(4):637-43. doi: 10.1189/jlb.0809577. Epub 2009 Dec 30. J Leukoc Biol. 2010. PMID: 20042470

9

Isolation of immature primary Langerhans cells from human epidermal skin.

de Jong MA, de Witte L, Geijtenbeek TB. de Jong MA, et al. Methods Mol Biol. 2010;595:55-65. doi: 10.1007/978-1-60761-421-0_4. Methods Mol Biol. 2010. PMID: 19941105

10

Salp15 binding to DC-SIGN inhibits cytokine expression by impairing both nucleosome remodeling and mRNA stabilization.

Hovius JW, de Jong MA, den Dunnen J, Litjens M, Fikrig E, van der Poll T, Gringhuis SI, Geijtenbeek TB. Hovius JW, et al. PLoS Pathog. 2008 Feb 8;4(2):e31. doi: 10.1371/journal.ppat.0040031. PLoS Pathog. 2008. PMID: 18282094 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page